Results 131 to 140 of about 46,100 (197)

Unveiling the Impact of Drug-Sensitive Mutations on HIV-1 Protease Dynamics: A Molecular Dynamics Simulation Study of the T12A, L63Q, and H69N Variants. [PDF]

Int J Mol Sci
Srihi H, Abid N, Fabeni L, Precone C, Déméné H, Chillemi G.   +5 more
europepmc   +1 more source

Effectiveness of yoga therapy as an adjunct on mental health status, quality of life, and medication adherence among people living with HIV on antiretroviral therapy: A study protocol of a randomized controlled trial (ART YOGA). [PDF]

PLoS One
Dhanlika D, Haldar P, Nischal N, Wig N, Singh S, Singh U, Sagar R, Das BK, Ranjan S, Sharma G.   +9 more
europepmc   +1 more source

Paradoxical Immune Reconstitution Inflammatory Syndrome Presenting as Extrapulmonary Tuberculosis in a Patient With HIV. [PDF]

Cureus
Shang W, Bruno TF.
europepmc   +1 more source

Trends in HIV Viral Suppression in the POP-UP Low-Barrier Care Program for People With HIV Experiencing Homelessness or Unstable Housing. [PDF]

Open Forum Infect Dis
Imbert E, Fleming L, Oskarsson J, Cullen C, Shiels M, Friend J, Jackson J, Felten L, Zahedikia N, Montgomery F, Santos L, Mayorga-Munoz F, Rodriguez Y, Breganza Y, Grochowski J, Cohen J, Appa A, Koester K, Erguera X, Charlebois E, Gandhi M, Havlir DV, Christopoulos K, Hickey MD.   +23 more
europepmc   +1 more source

Multidrug-resistant tuberculosis (MDR-TB) in people living with HIV: Clinical issues, therapeutic challenges and perspectives in sub-Saharan Africa. A narrative review. [PDF]

J Clin Tuberc Other Mycobact Dis
Tague C.
europepmc   +1 more source

Non-Surgical Periodontal Treatment Outcomes in Patients with HIV Under Antiretroviral Therapy: A Systematic Review. [PDF]

J Clin Med
Angelopoulou T, Bobetsis YA.
europepmc   +1 more source

Editorial Note: Incidence and predictors of HIV related opportunistic infections after initiation of highly active antiretroviral therapy at Ayder Referral Hospital, Mekelle, Ethiopia: A retrospective single centered cohort study. [PDF]

PLoS One
PLOS One Editors.
europepmc   +1 more source

Exploring the impact of baseline and on-treatment variables on durability of responses to fostemsavir through weeks 96 and 192 in the phase 3 BRIGHTE study. [PDF]

HIV Med
Gartland M, Wang X, Liao Q, Li B, Du F, Krystal M, Tenorio AR, Pierce A, Castillo-Mancilla JR.   +8 more
europepmc   +1 more source

Positioning HIV SMRTcap within the HIV reservoir toolbox. [PDF]

PLoS Pathog
Loddo A, Delobel P, Vellas C.
europepmc   +1 more source

Immunological research landscapes and emerging immune mechanisms in HIV/HBV co-infection: a bibliometric analysis (2014-2024). [PDF]

Front Immunol
Peng A, Waleed K, Qiu L, Wang L, Tong X, Tu Z, Li Z, Cui Y, Hu F, Yang S, Lu L, Huang P.   +11 more
europepmc   +1 more source